Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1978 18
1979 36
1980 59
1981 65
1982 59
1983 101
1984 81
1985 82
1986 96
1987 80
1988 85
1989 70
1990 54
1991 54
1992 54
1993 42
1994 52
1995 74
1996 71
1997 54
1998 54
1999 69
2000 67
2001 72
2002 75
2003 77
2004 83
2005 91
2006 95
2007 69
2008 64
2009 75
2010 96
2011 60
2012 77
2013 82
2014 63
2015 65
2016 67
2017 70
2018 67
2019 59
2020 60
2021 43
2022 41
2023 35
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

2,919 results

Results by year

Filters applied: . Clear all
Page 1
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
Waxman A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, Engel P, Bajwa A, Allen R, Feldman J, Argula R, Smith P, Rollins K, Deng C, Peterson L, Bell H, Tapson V, Nathan SD. Waxman A, et al. N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13. N Engl J Med. 2021. PMID: 33440084 Clinical Trial.
Prostacyclins.
Olschewski H. Olschewski H. Handb Exp Pharmacol. 2013;218:177-98. doi: 10.1007/978-3-642-38664-0_8. Handb Exp Pharmacol. 2013. PMID: 24092341 Review.
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.
Nathan SD, Waxman A, Rajagopal S, Case A, Johri S, DuBrock H, De La Zerda DJ, Sahay S, King C, Melendres-Groves L, Smith P, Shen E, Edwards LD, Nelsen A, Tapson VF. Nathan SD, et al. Lancet Respir Med. 2021 Nov;9(11):1266-1274. doi: 10.1016/S2213-2600(21)00165-X. Epub 2021 Jun 29. Lancet Respir Med. 2021. PMID: 34214475 Clinical Trial.
Pharmacotherapy of refractory pulmonary arterial hypertension.
Ahmed MS, Ghallab M, Ostrow T, Nashawi M, Alagha Z, Levine A, Aronow WS, Lanier GM. Ahmed MS, et al. Expert Opin Pharmacother. 2023 Sep-Dec;24(17):1861-1874. doi: 10.1080/14656566.2023.2257134. Epub 2023 Sep 12. Expert Opin Pharmacother. 2023. PMID: 37698041 Review.
Aerosolized prostacyclins.
Siobal M. Siobal M. Respir Care. 2004 Jun;49(6):640-52. Respir Care. 2004. PMID: 15165299 Free article. Review.
Management of Pulmonary Arterial Hypertension.
Weatherald J, Varughese RA, Liu J, Humbert M. Weatherald J, et al. Semin Respir Crit Care Med. 2023 Dec;44(6):746-761. doi: 10.1055/s-0043-1770118. Epub 2023 Jun 27. Semin Respir Crit Care Med. 2023. PMID: 37369218
Prostacyclins in Cardiac Surgery: Coming of Age.
Deshpande SP, Mazzeffi MA, Strauss E, Hollis A, Tanaka KA. Deshpande SP, et al. Semin Cardiothorac Vasc Anesth. 2018 Sep;22(3):306-323. doi: 10.1177/1089253217749298. Epub 2017 Dec 25. Semin Cardiothorac Vasc Anesth. 2018. PMID: 29277148 Review.
Clinical trials in group 3 pulmonary hypertension.
Harder EM, Waxman AB. Harder EM, et al. Curr Opin Pulm Med. 2020 Sep;26(5):391-396. doi: 10.1097/MCP.0000000000000694. Curr Opin Pulm Med. 2020. PMID: 32657833 Review.
2,919 results